what is gip and glp 1 GLP-1 & Agonists | Obesity Diabetes Management | Harrison's updates (22nd Ed.) The mechanism of GLP-1 and

[DOI] [PMC free article] [PubMed] [Google Scholar] 67.Wang D, et al

Diabetes Obes Metab 22(12):23642374

Although I do not routinely measure longitudinal change in body composition or bone mass in people taking GLP-1s, mostly because of the cost of DXA scans, significant muscle or bone loss are two objective manifestations of excessive weight loss that should lead to stopping or slowing treatment

found that the use of exenatide once weekly has nonsignificant effects on LDL-C levels with a change of -0.05 mmol/L 0.05 mmol/L, suggesting that the effect of GLP-1 RAs on LDL-C levels requires further research [67]

[DOI] [PMC free article] [PubMed] [Google Scholar] 7.Willard F